NASDAQ: SCTX
Scribe Therapeutics Inc Earnings Dates, Reports, Calls

Scribe Therapeutics earnings were N/A for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest SCTX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$6.5M, down 62.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SCTX reported annual earnings of -$21.8M, with -54.4% growth. The next SCTX earnings date is Dec 2, 2026.

SCTX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

SCTX Return on Equity

Insufficient data to display

SCTX Return on Assets

Insufficient data to display

Be the first to know when SCTX announces earnings.

SCTX Return on Capital Employed

Current Company
0%
Current Industry
-7.4%

SCTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SCTXN/AN/AN/AN/A
BNTC-$45.07M-$45.55MN/A-$0.98
EIKNN/AN/AN/AN/A
AGEN$155.84M$91.80M+7.29%$2.65
PRLD-$57.36M-$60.49MN/A-$0.73

SCTX earnings dates

Next earnings date
Dec 2, 2026

Scribe Therapeutics Earnings Reports & History FAQ

What were Scribe Therapeutics's earnings last quarter?

Scribe Therapeutics (NASDAQ: SCTX) reported Q2 2026 earnings per share (EPS) of -$2.62, up 35.78% year over year. Total SCTX earnings for the quarter were -$6.48 million. In the same quarter last year, Scribe Therapeutics's earnings per share (EPS) was -$4.08.

If you're new to stock investing, here's how to buy Scribe Therapeutics stock.

When does Scribe Therapeutics report earnings?

The next SCTX earnings date is Dec 2, 2026. Add SCTX to your watchlist to be reminded of Scribe Therapeutics's next earnings date.

Is Scribe Therapeutics profitable or losing money?

As of the last Scribe Therapeutics earnings report, Scribe Therapeutics is currently losing money. Scribe Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was N/A, a N/A decrease year over year.

What was SCTX's earnings growth in the past year?

As of Scribe Therapeutics's earnings date in Q4 2026, Scribe Therapeutics's earnings has grown year over year. SCTX earnings in the past year totalled N/A.

What are Scribe Therapeutics's earnings expectations?

The current EPS estimate for Scribe Therapeutics's earnings report in Dec 2, 2026 is -$0.42.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.